SAT-452 Results from the Phase 3 Multicenter SONICS Study of Levoketoconazole: Subgroup Analysis of Cushing's Syndrome (CS) Patients with Diabetes Mellitus (DM)

Background: Cushing’s syndrome (CS) has numerous comorbidities, including diabetes mellitus (DM).(1) Levoketoconazole is a ketoconazole stereoisomer in clinical trials for the treatment of CS. Methods: SONICS is a prospective, open-label, phase 3 maintenance-of-benefit study in adults with confirmed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Endocr Soc
Main Authors: Fleseriu, Maria, Pivonello, Rosario, Elenkova, Atanaska, Salvatori, Roberto, Auchus, Richard, Feelders, Richard, Geer, Eliza, Greenman, Yona, Witek, Przemyslaw, Cohen, Fredric, Biller, Beverly MK
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2019
Assuntos:
Neuroendocrinology and Pituitary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551748/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-452
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados